KALA - Kala Pharmaceuticals Inc. (KALA) CEO Mark Iwicki on Q2 2020 Results - Earnings Call Transcript
Kala Pharmaceuticals, Inc. (KALA)
Q2 2020 Earnings Conference Call
August 06, 2020, 08:00 AM ET
Company Participants
Niranjan Kameswaran - SVP, Strategy
Mary Reumuth - CFO
Mark Iwicki - Chairman, President and CEO
Kim Brazzell - Chief Medical Officer
Todd Bazemore - COO
Hongming Chen - Chief Scientific Officer
Conference Call Participants
Christopher Neyor - JPMorgan
Kit Ma - Jefferies
Yi Chen - H.C. Wainwright
François Brisebois - Oppenheimer
Tazeen Ahmad - Bank of America
Andreas Argyrides - Wedbush Securities
Presentation
Operator
Good morning, and welcome to Kala Pharmaceuticals Second Quarter 2020 Financial Results Conference